Library

By pinki shah / May 14, 2022

Displaying 2,076 - 2,100 of 2,995

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

By: Natalie Lui, MD, MAS

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

By: Natalie Lui, MD, MAS

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

By: Natalie Lui, MD, MAS

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

By: Natalie Lui, MD, MAS

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

By: Natasha B. Leighl, MD, MMSc, FRCPC, FASCO

Common and Uncommon Mutations - What Is Next for These Patient Populations

Common and Uncommon Mutations - What Is Next for These Patient Populations

By: Natasha Leighl MD

NRG1 as Target in NSCLC?

NRG1 as Target in NSCLC?

By: Natasha Leighl, MD

NRG1 as Target in NSCLC?

NRG1 as Target in NSCLC?

By: Natasha Leighl, MD

Other Oncogene-Driven Cancers

Other Oncogene-Driven Cancers

By: Nathaniel Myall, MD

Other Oncogene-Driven Cancers

Other Oncogene-Driven Cancers

By: Nathaniel Myall, MD

Other Oncogene-Driven Cancers

Other Oncogene-Driven Cancers

By: Nathaniel Myall, MD

Other Immunotherapy Targets & Agents- Advanced NSCLC

Other Immunotherapy Targets & Agents- Advanced NSCLC

By: Nathaniel Myall, MD, MS

Other Immunotherapy Targets & Agents- Advanced NSCLC

Other Immunotherapy Targets & Agents- Advanced NSCLC

By: Nathaniel Myall, MD, MS

ALK, ROS1, and BRAF Positive Lung Cancer

ALK, ROS1, and BRAF Positive Lung Cancer

By: Nathaniel Myall, MD, MS; Presented by: Heather Wakelee, MD

ALK, ROS1, and BRAF Positive Lung Cancer

ALK, ROS1, and BRAF Positive Lung Cancer

By: Nathaniel Myall, MD, MS; Presented by: Heather Wakelee, MD

Pulmonary - From Diagnostics to Therapeutics

Pulmonary - From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Nicholas Stollenwerk, MD

Robotic assisted Lung ablations

Robotic assisted Lung ablations

By: Nicos Fotiadis, MD, PhD

ADC in NSCLC: Too Much Hope?

ADC in NSCLC: Too Much Hope?

By: Noman Ashraf, MD